drugset / Trial / NCT02425878

Ulipristal Acetate 10 mg and Asisted Reproduction

NCT02425878

RandomizedParallel-groupDouble-blindTreatment

Summary

Demonstrate an 15% increase in the rate of clinical pregnancy in women with inoperable intramural fibroids not distorting the uterine cavity within a program OVD, after administration of uPA in a dose of 10 mg orally daily for 12 weeks

Timeline

Start
2015-10-19
Primary completion
2016-05-31
Completion
2016-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulipristal Acetate Unknown 10 mg Oral